Top 5 Health Care Stocks That Could Blast Off This Month
Portfolio Pulse from Lisa Levin
The article lists the top 5 oversold health care stocks, which are Cano Health, Inc. (CANO), Kezar Life Sciences, Inc. (KZR), BioLife Solutions, Inc. (BLFS), Allakos Inc. (ALLK), and Alaunos Therapeutics, Inc. (TCRT). These stocks have an RSI value below 30, indicating they are oversold and may present a buying opportunity. The companies have recently reported their Q2 financial results, with most of them performing worse than expected.
August 21, 2023 | 11:32 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Allakos posted a narrower-than-expected quarterly loss. Its stock fell 6.2% to close at $3.10 on Friday.
Despite a narrower-than-expected loss, Allakos' stock price fell, which could indicate a negative sentiment among investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
BioLife Solutions reported worse-than-expected Q2 results. Its stock fell 6.3% to close at $10.81 on Friday.
BioLife Solutions' poor Q2 results could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cano Health reported worse-than-expected Q2 results and is pursuing a sale process. Its stock fell 10.7% to close at $0.3703 on Friday.
Cano Health's poor Q2 results and the announcement of a sale process could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Kezar Life Sciences reported a YoY decrease in Q2 EPS results. Its stock fell 7.2% to close at $1.29 on Friday.
Kezar Life Sciences' decrease in Q2 EPS results could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Alaunos Therapeutics announced Q2 results, interim clinical data, and the exploration of strategic alternatives. Its stock fell 5.9% to close at $0.1234 on Friday.
Alaunos Therapeutics' announcement of exploring strategic alternatives could create uncertainty among investors, negatively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100